Our mission is to help people live longer, healthier lives.

Breathe BioMedical™ is developing a powerful technology platform that is poised to detect common, often deadly, diseases using only breath.

Breathe BioMedical is making early disease detection of cancer and other diseases through breath analysis the new standard for routine screening and improving clinical trial outcomes.

Our technology works by identifying the biomarkers of disease. We have active studies in lung cancer and breast cancer and are planning studies in Parkinson’s and Alzheimer’s Disease. This technology will revolutionize multi-disease screening.

Our vision is to make our simple breath test available in physician offices, clinics and even pharmacies. In a single test we will screen for numerous diseases. Long before symptoms appear, people of all walks of life will gain unprecedented knowledge of their health.

And all you have to do is breathe.

Breathe BioMedical is a wholly owned subsidiary of Picomole